Biomedical Engineering Reference
In-Depth Information
Kang, Y. 2005. Functional genomic analysis of cancer metastasis: biologic insights and
clinical implications. Expert Review of Molecular Diagnostics 5 (3): 385-395.
Kang, Y., Siegel, R., Shu, W., Drobnjak, M., Kakonen, S., et al. 2003. A multigenic program
mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
Kaplan, R., Riba, R., Zacharoulis, S., Bramley, A., Vincent, L., et al. 2005. VEGFR1-positive
haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:
820-827.
Kim, C., Kackson, E., Woolfenden, A., et al. 2005. Identification of bronchioalveolar stem
cells in normal lung and lung cancer. Cell 121: 823-835.
Kollet, O., Dar, A., Shivtiel, S., Kalinkovixh, A., Lapid, K., et al. 2006. Osteoclasts degrade
endosteal components and promote mobilizations of hematopoietic progenitor cells.
Nature Medicine 12: 657-664.
Krause, D., Lazarides, K., van Andrian, U., and van Etten, R. 2006. Requirement for CD44
in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nature Medicine
12: 1175-1180.
Krivtsov, A., Twomey, D., Feng, Z., Stubbs, M., Wang, Y., et al. 2006. Transformation from
committed progenitor to leukaemia stem cell initiated byMLL-AF9. Nature 442: 821-822.
Li, L. and Neaves, W. 2006. Normal stem cells and cancer stem cells: the niche matters. Cancer
Research 66: 4553-4557.
Li, F., Tiede, B., Massague, J., and Kang, Y. 2006. Beyond tumorigenesis: cancer stem cells in
metastasis. Cell Research 17: 3-14.
Lin, M. and Sessa, W. 2004. Antiangiogenic therapy: creating a unique "window" of oppor-
tunity. Cancer Cell 6: 529-531.
Ma, S., Lee, T., Zheng, B., Chan, K., and Guan, X. 2008. CD133(+) HCC cancer stem cells
confer chemoresistance by preferential expression of the Akt/PKB survival pathway.
Oncogene 27: 1749-1758.
Mihai, R., Stevens, J., McKinney, C., and Ibrahim, N.B. 2006. Expression of the calcium
receptor in human breast cancer—a potential new marker predicting the risk of bone
metastases. European Journal of Surgical Oncology 32 (5): 511-515.
Minn, A.J., Gupta, G.P., Siegel, P.M., et al. 2005a. Genes that mediate breast cancer
metastasis to lung. Nature 436: 518-524.
Minn, A.J., Kang, Y., Serganova, I., Gupta, G.P., Giri, D., Doubrovin, M., Ponomarev, V.,
Gerald, W., Blasberg, R., and Massague, J. 2005b. Distinct organ-specific metastatic
potential of individual breast cancer cells and primary tumors. The Journal of Clinical
Investigation 115: 44-55.
Miyamoto, T., Weissman, I., and Akashi, K. 2000. AML1/ETO-expressing nonleukemic stem
cells in acute myelogenous leukemia with 8:21 chromosomal translocation. Proceedings of
the National Academy of Science USA 97: 7521-7526.
Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T.,
Murphy, E., Yuan, W., Wagner, S.N., Barrera, J.L., Mohar, A., Verastegui, E., and
Zlotnik, A. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature
410 (6824): 50-56.
Paget, S. 1989. The distribution of secondary growths in cancer of the breast. 1889. Cancer
Metastasis Reviews 8 (2): 98-101.
Perou, C., Jeffrey, S., Van De Rinj, M., Rees, C., Wisen, M., et al. 1999. Distinctive gene
expression patterns in human mammary epithelial cells and breast cancers. Proceedings of
the National Academy of Science USA 2002: 9212-9217.
Phillips, T., McBride, W., and Pajonk, F. 2006. The response of CD24(-/low)/CD44+ breast
cancer initiating cells to radiation. Journal of the National Cancer Institute 98: 1777-1785.
Piccirillo, S., Reynolds, B., Zanetti, N., et al. 2006. Bone morphogenic proteins inhibit the
tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765.
Ramaswamy, S., Ross, K., Lander, E., and Golub, T. 2003. A molecular signature of
metastasis in primary solid tumors. Nature Genetics 33: 49-54.
